Children's Motrin Cold is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 10, 2019. Details of Children's Motrin Cold's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6211246 | Rapidly absorbed liquid compositions |
Jun, 2019
(5 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Children's Motrin Cold is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Children's Motrin Cold's family patents as well as insights into ongoing legal events on those patents.
Children's Motrin Cold's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Children's Motrin Cold's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 10, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Children's Motrin Cold Generics:
There are no approved generic versions for Children's Motrin Cold as of now.
About Children's Motrin Cold
Children'S Motrin Cold is a drug owned by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div. Children'S Motrin Cold uses Ibuprofen; Pseudoephedrine Hydrochloride as an active ingredient. Children'S Motrin Cold was launched by J And J Consumer Inc in 2000.
Approval Date:
Children's Motrin Cold was approved by FDA for market use on 01 August, 2000.
Active Ingredient:
Children's Motrin Cold uses Ibuprofen; Pseudoephedrine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Ibuprofen; Pseudoephedrine Hydrochloride ingredient
Dosage:
Children's Motrin Cold is available in suspension form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 100MG/5ML;15MG/5ML | SUSPENSION | Over the counter | ORAL |